The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- National Dental Commission India 2026:A Structural Overhaul of Indian Dental Education
- The Biology Beneath the Bite: Occlusion, Implants, and the Logic That Governs Both
- 105 Days on an Artificial Heart: How the BiVACOR Breakthrough Is Changing Patient Care Beyond Cardiology
- A Morning Reflection: Why AI Matters — and Why I Matter Too
- Guided Enamel Remineralisation and Resin Infiltration: Moving from Restoration to Regeneration in Early Caries
Archives